Neurology

Replacing regular salt with a reduced-sodium, added-potassium substitute significantly lowered recurrent stroke and mortality risk in stroke patients.

Delayed REM sleep may indicate early Alzheimer’s, with longer REM latency linked to increased toxic protein levels and reduced neuroprotective factors.

Microplastics are accumulating in human brains at increasing levels, with potential links to dementia and other neurological concerns.

A deep-learning algorithm predicts Parkinson’s disease using medical claims and prescriptions, improving early detection and clinical screening.

A recent ARTESiA trial analysis suggests apixaban may reduce stroke risk in patients with subclinical atrial fibrillation and a history of stroke

Intranasal oxytocin every third day modestly reduced apathy in frontotemporal dementia patients, offering a potential treatment approach.

Butylphthalide reduces cognitive decline in stroke survivors over 12 months, offering promising neuroprotection for post-stroke care.

Ophthalmic complications linked to semaglutide and tirzepatide raise concerns for diabetic patients on these medications.